Our Views

Big Pharma is getting smaller, with 40,000 jobs lost already and more to come, reports Guardian Unlimited. But don’t get too excited about it - it’s unlikely that the shrinking of Big Pharma’s massively rich corporations will reduce prescription drug addiction and dependency, or the growing need to handle it with drug detox.

According to the Guardian article, Swiss drug maker Novartis AG has announced a layoff of 2,500 employees – and this is only the latest in a rash of desperate cost-cutting measures made by Big Pharma. Just a week ago, Bristol-Myers Squibb announced plans to dump 10 percent of its work force and close some plants, and French drug firm Sanofi-Aventis has announced spending cuts. All the other big players have already taken steps to meet shrinking profit margins, including Pfizer, AstraZeneca, Merck, GlaxoSmithKline, Amgen, Schering-Plough, Eli Lilly and Johnson & Johnson.

The cut-backs reflect a slow-down in pharmaceuticals growth because research labs have failed to deliver new drugs on time, competition from generic drugs is increasing, patents are expiring on profitable brand-name drugs, and the pressure on prices continues to increase. Some Big Pharma players are divesting themselves of non-pharma business interests, while others are cutting less profitable operations.
 
In spite of the slowdown in the drug industry, the need for drug detox in America and abroad will continue to increase, not decrease, and perhaps increase even faster than before. Millions of people are already dependent on prescription drugs with no safety net other than a good drug detox program. The loss of valuable drug patents, for example, will just mean that addictive and debilitating drugs will be cheaper, and even more available, which of course can only lead to the need for more drug detox, not less.

If you have a friend or family member who needs a prescription drug detox program, call Novus Detox today. We are prescription drug detox experts.

Popularity: 24% [?]